Americafirst Capital Management’s Zimmer Biomet ZBH Stock Holding History

Americafirst Capital Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,106	Closed	-$211K	–	257
2016 Q4	$211K	Sell	2,106 -12,062	-85%	-$1.29M	0.22%	117
2016 Q3	$1.79M	Buy	+14,168	New	+$1.75M	1.49%	10
2015 Q2	–	Sell	-12,740	Closed	-$1.45M	–	291
2015 Q1	$1.45M	Buy	+12,740	New	+$1.45M	0.72%	49

Other funds holding ZBH

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Americafirst Capital Management's ZBH Position: Q1 2017 in Review

Americafirst Capital Management sold out of Zimmer Biomet (ZBH) in Q1 2017, closing a stake of 2,106 shares — an estimated $211K sold.

Americafirst Capital Management first reported a position in ZBH in Q1 2015 and held it in 3 quarters. The position peaked at $1.79M in Q3 2016. 817 funds tracked by Wall St. Rank hold ZBH as of Q1 2017.

Americafirst Capital Management reported no remaining Zimmer Biomet position as of Q1 2017 after selling out during the quarter.
Americafirst Capital Management sold 2,106 Zimmer Biomet shares in Q1 2017, an estimated $211K.
Americafirst Capital Management first reported a position in Zimmer Biomet in Q1 2015 and held it in 3 quarters.
Americafirst Capital Management's Zimmer Biomet position peaked at $1.79M in Q3 2016.
817 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2017.

Based on Americafirst Capital Management's 13F filing for Q1 2017, filed 17 Apr 2017.